190 related articles for article (PubMed ID: 3105140)
1. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
[No Abstract] [Full Text] [Related]
2. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Kremer AB; Barnes L; Hirsch RL; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
[No Abstract] [Full Text] [Related]
3. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
[TBL] [Abstract][Full Text] [Related]
5. Reversing cardiac transplant rejection with Orthoclone OKT3.
Dault LA; Nagy CS; Collins JA
Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
[No Abstract] [Full Text] [Related]
6. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
Moore CK; O'Connell JB; Renlund DG; Bristow MR; Hammond EH
Transplant Proc; 1991 Feb; 23(1 Pt 2):1055-8. PubMed ID: 1899151
[No Abstract] [Full Text] [Related]
7. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
8. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
[TBL] [Abstract][Full Text] [Related]
9. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
[No Abstract] [Full Text] [Related]
10. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
O'Connell JB; Renlund DG; Hammond EH; Wittwer CT; Yowell RL; DeWitt CW; Jones KW; Gay WA; Menlove RL; Bristow MR
J Heart Lung Transplant; 1991; 10(2):217-21; discussion 221-2. PubMed ID: 1903303
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation.
Kormos RL; Herlan DB; Armitage JM; Stein K; Kaufman C; Zeevi A; Duquesnoy R; Hardesty RL; Griffith BP
J Heart Transplant; 1990; 9(1):1-9, discussion 9-10. PubMed ID: 2107288
[TBL] [Abstract][Full Text] [Related]
12. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.
Kahana L; Ackermann J; Lefor W; Weinstein S; Wright C; DeQuesada A; Alveranga D; Baxter J; Shires D
Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799
[TBL] [Abstract][Full Text] [Related]
13. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
[No Abstract] [Full Text] [Related]
14. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
15. Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.
Frist WH; Gerhardt EB; Merrill WH; Atkinson JB; Eastburn TE; Stewart JR; Hammon JW; Bender HW
J Heart Transplant; 1990; 9(6):724-6. PubMed ID: 2126035
[TBL] [Abstract][Full Text] [Related]
16. Orthoclone OKT3 and cardiac transplantation: an overview.
Mahon PM
Crit Care Nurse; 1991 Sep; 11(8):42-7, 50. PubMed ID: 1909947
[No Abstract] [Full Text] [Related]
17. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
[No Abstract] [Full Text] [Related]
18. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
19. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.
Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E
Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody OKT3 in cardiac and renal transplantation.
Norman DJ
Bibl Cardiol; 1988; (43):27-32. PubMed ID: 3147656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
